Download PDF
1 / Pages

Other users also viewed these articles

Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children Wilson Toyohiro Hoshino; Adriana Maria Paixão De Sousa da Silva; Antonio Carlos Pignatari; Ana Cristina Gales; Fabianne Carlesse;
10.1016/j.bjid.2025.104515
Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit Jorge Alberto Cortés; Martha Carolina Valderrama-Rios; Paula M. Peçanha-Pietrobom; Moacyr Silva Júnior; Cándida Diaz-Brochero; Rafael Ricardo Robles-Torres; Carmelo José Espinosa-Almanza; Laura Cristina Nocua-Báez; Marcio Nucci; Carlos Arturo Álvarez-Moreno; Flavio Queiroz-Telles; Ricardo Rabagliati; Rita Rojas-Fermín; Jorge L. Finquelievich; Fernando Riera; Patricia Cornejo-Juárez; Dora E. Corzo-León; Luis E. Cuéllar; Jeannete Zurita; Augusto Raúl Hernández; Arnaldo Lopes Colombo;
10.1016/j.bjid.2024.104495
Activity of ceftolozane/tazobactam and comparators against gram-negative bacilli: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART ¿ Brazil), 2018¿2021 Amanda Azevedo Bittencourt; Vinicius Lima Faustino; Paula de Mendonça Batista; Lays Paulino Leonel; Marina Della Negra de Paula; Thales José Polis;
10.1016/j.bjid.2024.104497